{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:35:49Z","timestamp":1791909349935,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jtcvs.2020.11.106","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T04:29:43Z","timestamp":1608179383000},"page":"836-843.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Smita","family":"Sihag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey Y.","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay See","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena Y.","family":"Janjigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Molena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2020.11.106_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","article-title":"Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in Oncology","volume":"17","author":"Ajani","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib3","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib4","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1200\/JCO.2018.36.15_suppl.4012","article-title":"Survival outcomes from CALGB 80803 (Alliance): a randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer","volume":"36","author":"Goodman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.thorsurg.2020.01.001","article-title":"Adjuvant and neoadjuvant immunotherapy in non-small cell lung cancer","volume":"30","author":"Broderick","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib6","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1158\/1078-0432.CCR-18-2641","article-title":"The promise of neoadjuvant immunotherapy and surgery for cancer treatment","volume":"25","author":"O'Donnell","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib7","doi-asserted-by":"crossref","first-page":"eaax0182","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtcvs.2018.11.124","article-title":"Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer","volume":"158","author":"Bott","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib11","doi-asserted-by":"crossref","first-page":"112103","DOI":"10.18632\/oncotarget.22783","article-title":"Hypermutation and microsatellite instability in gastrointestinal cancers","volume":"8","author":"Yuza","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.hoc.2018.12.007","article-title":"The current status of immunotherapies in esophagogastric cancer","volume":"33","author":"Ku","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib13","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.2017.76.6212","article-title":"CheckMate-032 Study: efficacy and safety of nivolumab and nivolumab plus ipilimumab in patients with metastatic esophagogastric cancer","volume":"36","author":"Janjigian","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.athoracsur.2016.10.027","article-title":"The Society of Thoracic Surgeons composite score for evaluating esophagectomy for esophageal cancer","volume":"103","author":"Society of Thoracic Surgeons General Thoracic Surgery Database Task Force","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jtcvs.2008.11.042","article-title":"Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model","volume":"137","author":"Wright","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1067\/mtc.2000.105644","article-title":"Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer","volume":"119","author":"Swisher","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.11.106_bib18","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.athoracsur.2017.03.038","article-title":"Initial experience with lung cancer resection after treatment with T-cell checkpoint inhibitors","volume":"104","author":"Chaft","year":"2017","journal-title":"Ann Thorac Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320331925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320331925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:13:03Z","timestamp":1758388383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522320331925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0022522320331925"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.11.106","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.11.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}